Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology: working group report

S E Gabriel; P Tugwell; M Drummond

Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology: working group report

S E Gabriel, P Tugwell, M Drummond

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Abstract

A working report from the OMERACT Health Economics Group. The group is working towards creating common standards for economic evaluation in rheumatology and also towards improving the scientific underpinning of economic evaluation, particularly pertaining to the rheumatic diseases. Preliminary recommendations for "reference cases" in osteoporosis, rheumatoid arthritis, and osteoarthritis are proposed.

Original language	English
Pages (from-to)	370-373
Number of pages	4
Journal	Annals of the Rheumatic Diseases
Volume	61
Issue number	4
Publication status	Published - Apr 2002

Keywords

COST-EFFECTIVENESS ANALYSIS
OSTEOPOROSIS
ARTHRITIS
UTILITY
OSTEOARTHRITIS
CONTROVERSIES
DRUGS
LIFE

Cite this

@article{4418ab0792b3457682a1e4cef903792d,

title = "Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology: working group report",

abstract = "A working report from the OMERACT Health Economics Group. The group is working towards creating common standards for economic evaluation in rheumatology and also towards improving the scientific underpinning of economic evaluation, particularly pertaining to the rheumatic diseases. Preliminary recommendations for {"}reference cases{"} in osteoporosis, rheumatoid arthritis, and osteoarthritis are proposed.",

keywords = "COST-EFFECTIVENESS ANALYSIS, OSTEOPOROSIS, ARTHRITIS, UTILITY, OSTEOARTHRITIS, CONTROVERSIES, DRUGS, LIFE",

author = "Gabriel, {S E} and P Tugwell and M Drummond",

year = "2002",

month = apr,

language = "English",

volume = "61",

pages = "370--373",

journal = "Annals of the Rheumatic Diseases",

publisher = "BMJ",

number = "4",

}

TY - JOUR

T1 - Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology

T2 - working group report

AU - Gabriel, S E

AU - Tugwell, P

AU - Drummond, M

PY - 2002/4

Y1 - 2002/4

N2 - A working report from the OMERACT Health Economics Group. The group is working towards creating common standards for economic evaluation in rheumatology and also towards improving the scientific underpinning of economic evaluation, particularly pertaining to the rheumatic diseases. Preliminary recommendations for "reference cases" in osteoporosis, rheumatoid arthritis, and osteoarthritis are proposed.

AB - A working report from the OMERACT Health Economics Group. The group is working towards creating common standards for economic evaluation in rheumatology and also towards improving the scientific underpinning of economic evaluation, particularly pertaining to the rheumatic diseases. Preliminary recommendations for "reference cases" in osteoporosis, rheumatoid arthritis, and osteoarthritis are proposed.

KW - COST-EFFECTIVENESS ANALYSIS

KW - OSTEOPOROSIS

KW - ARTHRITIS

KW - UTILITY

KW - OSTEOARTHRITIS

KW - CONTROVERSIES

KW - DRUGS

KW - LIFE

M3 - Article

VL - 61

SP - 370

EP - 373

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 4

ER -